TxCell develops unique cellular immunotherapy platforms based on antigen-specific regulatory T cells for the treatment of severe autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders.

Company Growth (employees)
Type
Public
HQ
Valbonne, FR
Founded
2001
Size (employees)
45 (est)-6%
Website
txcell.com
TxCell was founded in 2001 and is headquartered in Valbonne, FR

Key People/Management at TxCell

Francois Meyer

Francois Meyer

CEO
Stéphane Boissel

Stéphane Boissel

CEO
Raphaël Flipo

Raphaël Flipo

SVP & CFO

TxCell Office Locations

TxCell has an office in Valbonne
Valbonne, FR (HQ)
Allée de la Nertière

TxCell Financials and Metrics

TxCell Financials

EUR

Market capitalization (31-Oct-2017)

31.3 m

Closing share price (31-Oct-2017)

1.6
TxCell's current market capitalization is €31.3 m.
Show all financial metrics

TxCell Market Value History

TxCell's Web-traffic and Trends

TxCell Online and Social Media Presence

TxCell Company Life and Culture

You may also be interested in